NCT00539760View on ClinicalTrials.gov

A Phase I Rheumatoid Arthritis Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 5, 2007

Primary Completion Date

April 5, 2008

Study Completion Date

April 5, 2008

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

GSK1827771

GSK1827771 will be administered using injection via subcutaneous (SC) route.

DRUG

Placebo

Placebo to GSK1827771 for Injection will be administered via SC route

Trial Locations (2)

21225

GSK Investigational Site, Baltimore

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY